• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Talking with Parents About Stimulant Treatment

Talking with Parents About Stimulant Treatment

March 24, 2022
John C. Raiss, MD.
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
John C. Raiss, MD. Assistant Clinical Professor of Child and Adolescent Psychiatry, UCLA David Geffen School of Medicine, Los Angeles, CA. Dr. Raiss has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.



After a thorough assessment, you diagnose your 16-year-old patient Alex with ADHD and recommend a trial of stimulant medication. Alex wants to try the medication, but his mother feels he just needs tips and skills to improve his focus and doesn’t need to “take pills for the rest of his life.”

ADHD is one of the most treatable conditions in psychiatry if patients adhere to medication regimens. Stimulants are widely used in treatment and are usually safe when taken as prescribed; however, parents are often skeptical and concerned about psychotropic medications. In this article we’ll talk about parental resistance to stimulant medications and how to best work with parents when discussing treatment.

Risks of ineffective therapies or avoiding treatment
Medication nonadherence or avoidance increases the morbidity of psychiatric ADHD conditions as patients are less likely to have their condition respond or remit. Common risks of untreated ADHD include (Biederman J et al, Psychiatric Services 2019;70(10):874–880):

  • Underachievement at school and work

  • Family conflict

  • Mood disorders

  • Anxiety disorders

  • Addiction

  • Injuries, including traumatic brain injury

  • Accidents

  • Premature death

  • Suicide


Results from questionnaires show that many parents believe that psychotropic medication can make children more likely to develop later drug addiction (Lazaratou H et al, Ann Gen Psychiatry 2007;6:32). The American Academy of Pediatrics recommends behavioral approaches (CBT) as the first treatment for ADHD for pre-school children, but not school -aged children , in line with the Multimodal Treatment Study of Children with Attention Deficit/Hyperactivity Disorder (MTA) which demonstrated that stimulant medications are more effective than behavioral treatments for core symptoms of ADHD in school-aged kids. Other reasons often cited by parents range from concern about weight related issues to stigma.

Parents may believe that supplements are natural and less harmful than stimulants, but with the possible exception of saffron, most supplements have little evidence of efficacy in ADHD. Long-chain polyunsaturated fatty acids and minerals have “at best marginal beneficial effects,” and zinc, iron, and magnesium lack convincing evidence (Lange KW et al, Curr Psychiatry Rep 2017;19(2):8). Micronutrients showed no effect either (Johnstone JM et al, JAACAP 2021; in press). Saffron is an exception and may be on par with methylphenidate (Baziar S et al, J Child Adolesc Psychopharmacol 2019;29(3):205–212, reviewed in CCPR November 2019).

At follow-up two weeks later, Alex reports that he is still unable to focus for even short periods of time. He is drinking products with excessive amounts of caffeine and pulling all-nighters to finish his work. You decide that you need to understand his mother’s concerns about stimulants more fully. She confides that she’s heard stories of kids misusing their medication. She also doesn’t want Alex to be labelled as “an ADHD kid.”

Talking with parents

  • Find out what each parent thinks about medication and what their hesitations or worries might be. A good way to initiate this conversation is to simply state, “Please help me understand your specific concerns.” Some parents are truly set against using medication, but most can engage in productive conversation. Once you know what their concerns are, you can take various approaches to encourage parents to partner with you in treating their child or teen. Some helpful tips for talking to medication-hesitant parents include:

  • Put medications in context. “Medications are part of an overall plan that includes exercise, structure, nutrition, and sleep.”

  • Share specifics. “Every medication has its good and bad points. Let’s go over them one by one in detail. And remember, we will learn very quickly whether the medication is helpful or not—most likely within a few weeks.”

  • Destigmatize treatment. “It might be unfair to your child if we don’t treat their symptoms. That might make their life unnecessarily difficult. Lots of kids have ADHD and are relieved to get treatment.”

  • Address family and cultural aspects. “Do you have family members with similar issues? How do people in your family and culture understand and manage ADHD symptoms?”

  • Discuss the benefits. “Most kids can focus better when they take these medications. They learn better and get their work done more easily, more like their friends and classmates. Kids often feel a lot better about their abilities, and they have more time for recreation and to enjoy life.”

  • Talk about the risks of not treating ADHD. “Kids who don’t get treatment struggle harder to get their work done. It takes them longer than their friends. They are often criticized for errors, failing to follow instructions, or not turning in assignments.”

  • Stress that treatment can have other benefits. “Treating ADHD can reduce the risk of accidents, substance use, depression, criminal activity, and teenage pregnancy” (Faraone SV et al, Neurosci Biobehav Rev 2021;128:789–818).

  • Acknowledge legitimate risks and their management. Be sure to directly address appetite, growth or weight loss issues, height, sleep, blood pressure, and pulse. “Stimulants can reduce appetite, so we will track growth. If your child is not eating enough, we can brainstorm some ideas together. We often use medication holidays during weekends and vacations, as well as other strategies to support growth and minimize the amount of medication you give to your child.”

  • Discuss sleep challenges. “If issues arise with sleep, we can adjust the timing of the medication to minimize these effects.”

  • Talk about drug interactions. “ADHD medications can be taken with most other prescriptions, including antidepressants and birth control pills. But we will need to talk about other meds your child is currently taking, including cold medications such as pseudoephedrine. And be sure to keep me updated about future prescribed or over-the-counter meds, as well as supplements.”

  • Discuss sexual side effects, even if parents and teens do not directly ask about them. “You may have heard that medications have sexual side effects. Stimulants can cause painful erections. This is rare, but you should seek rapid medical attention if that happens.”

  • Talk about addiction/diversion. “It is important for you to dispense the medication to your child and to keep careful control of it to prevent misuse, but stimulants actually can protect kids against substance misuse.”

  • Address possible barriers to prescriptions. “Many of these medications are covered by insurance, but some may need a prior authorization.” “These medications are more carefully controlled than most to avoid misuse—you may need to show identification when you pick it up.”


After talking about her concerns, Alex’s mother agrees to a careful one-month trial of stimulants. Alex has a rapid response to 10 mg of extended-release mixed amphetamine salts, and his focus improves. He has mild irritability in the afternoons, which improves with scheduled afternoon snacks. Over the course of the semester, Alex’s grades and confidence improve.

CCPR Verdict: The first three rules for helping parents understand the risks and benefits of ADHD medication are listen, listen, and listen. Address their concerns point by point and be sure they understand that medication can be life changing.
Child Psychiatry
KEYWORDS adhd collaboration parents stimulant-medications
    John C. Raiss, MD.

    Lumateperone in Bipolar Depression

    More from this author
    www.thecarlatreport.com
    Issue Date: March 24, 2022
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - ADHD in Children and Adolescents, CCPR, April/May/June 2022
    Note From the Editor-in-Chief
    The Evidence Base for Polypharmacy in ADHD
    Methylphenidate Improves Mood and Boredom in Children with ADHD
    Talking with Parents About Stimulant Treatment
    Treating Anxiety Disorders in Children: The New AACAP Clinical Practice Guideline
    Practical Issues with Prescribing ADHD Meds
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.